Legato Capital Management LLC Legend Biotech Corp Transaction History

Legato Capital Management LLC

  • $761 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 12, 2023
BUY
$63.16 - $76.5 $519,301 - $628,983
8,222 New
8,222 $552,000
Q2 2023

Aug 17, 2023
SELL
$46.28 - $75.01 $122,503 - $198,551
-2,647 Reduced 24.35%
8,222 $567,000
Q4 2022

Feb 01, 2023
BUY
$38.8 - $55.46 $421,717 - $602,794
10,869 New
10,869 $542,000

Others Institutions Holding LEGN

# of Institutions
225
Shares Held
74.3M
Call Options Held
279K
Put Options Held
350K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email